References
Ahmadi, H., & Daneshmand, S. (2013). Androgen deprivation therapy: Evidence-based management of side effects. BJU International, 111, 543-548. doi:10.1111/j.1464-410X.2012.11774.x
Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., … Naglie, G. (2010). Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology, 28, 5038-5045. doi:10.1200/JCO.2010.29.8091
Blanchard, C. M., Courneya, K. S., & Stein, K. (2008). Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society's SCS-II. Journal of Clinical Oncology, 26, 2198-2204.
Braga-Basaria, M., Dobs, A. S., Muller, D. C., Carducci, M. A., John, M., Egan, J., & Basaria, S. (2006). Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. Journal of Clinical Oncology, 24, 3979-3983.
Cormie, P., Galvão, D. A., Spry, N., Joseph, D., Chee, R., Taaffe, D. R., … Newton, R. U. (2014). Can supervised exercise prevent treatment toxicity in prostate cancer patients initiating androgen deprivation therapy: A randomised controlled trial. BJU International. Advance online publication. doi:10.1111/bju/12646
Cormie, P., Galvão, D. A., Spry, N., Joseph, D., Taaffe, D. R., & Newton, R. U. (2014). Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: Longitudinal results of a pilot study. Supportive Care in Cancer, 22, 1537-1548. doi:10.1007/s00520-013-2103-1
Cormie, P., Newton, R. U., Spry, N., Joseph, D., Taaffe, D. R., & Galvão, D. A. (2013). Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer and Prostatic Diseases, 16, 328-335. doi:10.1038/pcan.2013.22
Cormie, P., Newton, R. U., Taaffe, D. R., Spry, N., & Galvão, D. A. (2013). Exercise therapy for sexual dysfunction after prostate cancer. Nature Reviews. Urology, 10, 731-736. doi:10.1038/nrurol.2013.206
Cormie, P., Newton, R. U., Taaffe, D. R., Spry, N., Joseph, D., Akhlil Hamid, M., & Galvão, D. A. (2013). Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: A randomized controlled trial. Prostate Cancer and Prostatic Diseases, 16, 170-175.
Courneya, K. S., Stevinson, C., McNeely, M. L., Sellar, C. M., Friedenreich, C. M., Peddle-McIntyre, C. J., … Reiman, T. (2012). Effects of supervised exercise on motivational outcomes and longer-term behavior. Medicine and Science in Sports and Exercise, 44, 542-549. doi:10.1249/MSS.0b013e3182301e06
Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-being: A theory of gender and health. Social Science and Medicine, 50, 1385-1401. doi:10.1016/S0277-9536(99)00390-1
De Sousa, A., Sonavane, S., & Mehta, J. (2012). Psychological aspects of prostate cancer: A clinical review. Prostate Cancer and Prostatic Diseases, 15, 120-127. doi:10.1038/pcan.2011.66
Elliott, R., Fischer, C. T., & Rennie, D. L. (1999). Evolving guidelines for publication of qualitative research studies in psychology and related fields. British Journal of Clinical Psychology, 38, 215-229. doi:10.1348/014466599162782
Elo, S., & Kyngäs, H. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62, 107-115. doi:10.1111/j.1365-2648.2007.04569.x
Galdas, P. M., Cheater, F., & Marshall, P. (2005). Men and health help-seeking behaviour: Literature review. Journal of Advanced Nursing, 49, 616-623. doi:10.1111/j.1365-2648.2004.03331.x
Galvão, D. A., Spry, N., Denham, J., Taaffe, D. R., Cormie, P., Joseph, D., … Newton, R. U. (2013). A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. European Urology, 65, 856-864. doi:10.1016/j.eururo.2013.09.041
Galvão, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., … Prince, R. (2008). Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU International, 102, 44-47. doi:10.1111/j.1464-410X.07539.x
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010). Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. Journal of Clinical Oncology, 28, 340-347. doi:10.1200/JCO.2009.23.2488
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009). Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer and Prostatic Diseases, 12, 198-203. doi:10.1038/pcan.2008.51
Gough, B. (2013). The psychology of men's health: Maximizing masculine capital. Health Psychology, 32, 1-4. doi:10.1037/a0030424
Hamilton, E. J., Gianatti, E., Strauss, B. J., Wentworth, J., Lim-Joon, D., Bolton, D., … Grossmann, M. (2011). Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clinical Endocrinology (Oxford), 74, 377-383. doi:10.1111/j.1365-2265.2010.03942.x
Hamilton, K., Chambers, S. K., Legg, M., Oliffe, J. L., & Cormie, P. (2014). Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer. Supportive Care in Cancer. Advance online publication. doi:10.1007/s00520-014-2327-8
Harden, J., Sanda, M. G., Wei, J. T., Yarandi, H. N., Hembroff, L., Hardy, J., & Northouse, L. (2013). Survivorship after prostate cancer treatment: Spouses' quality of life at 36 months. Oncology Nursing Forum, 40, 567-573. doi:10.1188/13.ONF.567-573
Harrington, J. M., Jones, E. G., & Badger, T. (2009). Body image perceptions in men with prostate cancer. Oncology Nursing Forum, 36, 167-172. doi:10.1188/ONF.167-172
Harrington, J. M., Schwenke, D. C., & Epstein, D. R. (2013). Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy [Online exclusive]. Oncology Nursing Forum, 40, E358-E367. doi:10.1188/13.ONF.E358-E367
Harrington, J. M., Schwenke, D. C., Epstein, D. R., & Bailey, D. E., Jr. (2014). Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer. Oncology Nursing Forum, 41, 21-29. doi:10.1188/14.ONF.21-29
Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., Mason, M. D., … Zattoni, F. (2013). European Association of Urology: Guidelines on prostate cancer. Retrieved from
http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf
Higano, C. S. (2012). Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology, 30, 3720-3725. doi:10.1200/JCO.2012.41.8509
Humphries, B., Duncan, M. J., & Mummery, W. K. (2010). Prevalence and correlates of resistance training in a regional Australian population. British Journal of Sports Medicine, 44, 653-656. doi:10.1136/bjsm.2008.048975
Kenfield, S. A., Stampfer, M. J., Giovannucci, E., & Chan, J. M. (2011). Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. Journal of Clinical Oncology, 29, 726-732. doi:10.1200/JCO.2010.31.5226
Kruger, J., Carlson, S., & Kohl, H. (2006). Trends in strength training—United States, 1998-2004. Morbidity and Mortality Weekly Report, 55, 769-772.
Krumwiede, K. A., & Krumwiede, N. (2012). The lived experience of men diagnosed with prostate cancer [Online exclusive]. Oncology Nursing Forum, 39, E443-E450. doi:10.1188/12.ONF.E443-E450
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., … Zakai, N. (2010). Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology. Circulation, 121, 833-840. doi:10.1161.CIRCULATIONAHA.109.192695
Ng, E., Woo, H. H., Turner, S., Leong, E., Jackson, M., & Spry, N. (2012). The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: Observations from a prospective study in men undergoing intermittent androgen suppression. Journal of Urology, 187, 2162-2166. doi:10.1016/j.juro.2012.01.080
Oliffe, J. L., Halpin, M., Bottorff, J. L., Hislop, T. G., McKenzie, M., & Mroz, L. (2008). How prostate cancer support groups do and do not survive: British Columbian perspectives. American Journal of Men's Health, 2, 143-155. doi:10.1177/1557988307304147
Oliffe, J. L., Ogrodniczuk, J., Bottorff, J. L., Hislop, T. G., & Halpin, M. (2009). Connecting humor, health, and masculinities at prostate cancer support groups. Psycho-Oncology, 18, 916-926. doi:10.1002/pon.1415
Pachman, D. R., Barton, D. L., Swetz, K. M., & Loprinzi, C. L. (2012). Troublesome symptoms in cancer survivors: Fatigue, insomnia, neuropathy, and pain. Journal of Clinical Oncology, 30, 3687-3696. doi:10.1200/JCO.2012.41.7238
Resnick, B., Orwig, D., Magaziner, J., & Wynne, C. (2002). The effect of social support on exercise behavior in older adults. Clinical Nursing Research, 11, 52-70. doi:10.1177/105477380201100105
Resnick, M. J., Koyama, T., Fan, K. H., Albertsen, P. C., Goodman, M., Hamilton, A. S., … Penson, D. F. (2013). Long-term functional outcomes after treatment for localized prostate cancer. New England Journal of Medicine, 368, 436-445. doi:10.1056/NEJMoa1209978
Rock, C. L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., … Gansler, T. (2012). Nutrition and physical activity guidelines for cancer survivors. CA: A Cancer Journal for Clinicians, 62, 242-274. doi:10.3322/caac.21142
Saini, A., Berruti, A., Cracco, C., Sguazzotti, E., Porpiglia, F., Russo, L., … Ostacoli, L. (2013). Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. Urologic Oncology, 31, 352-358. doi:10.1016/j.urolonc.2011.02.005
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., … Wei, J. T. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine, 358, 1250-1261. doi:10.1056/NEJMoa074311
Segal, R. J., Reid, R. D., Courneya, K. S., Malone, S. C., Parliament, M. B., Scott, C. G., … Wells, G. A. (2003). Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology, 21, 1653-1659. doi:10.1200/JCO.2003.09.534
Segal, R. J., Reid, R. D., Courneya, K. S., Sigal, R. J., Kenny, G. P., Prud'Homme, D. G., … Slovinec D'Angelo, M. E. (2009). Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. Journal of Clinical Oncology, 27, 344-351. doi:10.1200/JCO.2007.15.4963
Shahinian, V. B., Kuo, Y. F., Freeman, J. L., & Goodwin, J. S. (2005). Risk of fracture after androgen deprivation for prostate cancer. New England Journal of Medicine, 352, 154-164. doi:10.1056/NEJMoa041943
Sloan, C., Gough, B., & Conner, M. (2010). Healthy masculinities? How ostensibly healthy men talk about lifestyle, health and gender. Psychology and Health, 25, 783-803. doi:10.1080/08870440902883204
Smith, J. A., & Osborn, M. (2013) Qualitative psychology: A practical guide to research methods. In J. A. Smith, P. Flowers, & M. Larkin (Eds.), Interpretative phenomenological analysis: Theory, method and research (pp. 51-80). Thousand Oaks, CA: Sage.
Smith, M. R., Saad, F., Egerdie, B., Sieber, P. R., Tammela, T. L., Ke, C., … Goessl, C. (2012). Sarcopenia during androgen-deprivation therapy for prostate cancer. Journal of Clinical Oncology, 30, 3271-3276. doi:10.1200/JCO.2011.38.8850
Spry, N. A., Galvão, D. A., Davies, R., La Bianca, S., Joseph, D., Davidson, A., & Prince, R. (2009). Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: Results of a 33-month observational study. BJU International, 104, 806-812. doi:10.1111/j.1464-410X.2009.08458.x
Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., … McCaul, K. (2006). Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. European Journal of Cancer, 42, 1083-1092. doi:10.1016/j.ejca.2006.01.029
Spry, N. A., Taaffe, D. R., England, P. J., Judge, J. S., Stephens, D. A., Peddle-McIntyre, C., … Galvão, D. A. (2013). Long-term effects of intermittent androgen suppression therapy on lean and fat mass: A 33-month prospective study. Prostate Cancer and Prostatic Diseases, 16, 67-72. doi:10.1038/pcan.2012.33
Thorson, J. A., Powell, F. C., Sarmany-Schuller, I., & Hampes, W. P. (1997). Psychological health and sense of humor. Journal of Clinical Psychology, 53, 605-619.